E-ISSN 2636-834X
 

Case Report 


Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder

Setenay Sarioglu, Ali Evren Tufan, Yusuf Ozturk, Dilara Ozdemir.

Abstract
Oro-mandibular dystonia (OMD) involves repetitive uncontrollable contractions of the lower facial muscles. Its etiology is not fully elucidated although various neurological (encephalitis, etc.), psy-chogenic, and psychopharmacological (SSRIs, antipsychotics, etc.) causes were implicated. Ado-lescent patients developing OMD after treatment with sertraline or fluoxetine alone were reported previously. In this case, we reported OMD in a patient with sequential trials of different SSRIs. Despite its rarity, this adverse effect may be borne in mind by clinicians.

Key words: Oro-mandibular Dystonia, Fluoxetine, Sertraline, Major Depressive Disorder


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Setenay Sarioglu
Articles by Ali Evren Tufan
Articles by Yusuf Ozturk
Articles by Dilara Ozdemir
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Sarioglu S, Tufan AE, Ozturk Y, Ozdemir D. Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder. PBS. 2022; 12(4): 210-211. doi:10.5455/PBS.20221012042348


Web Style

Sarioglu S, Tufan AE, Ozturk Y, Ozdemir D. Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder. https://www.pbsciences.org/?mno=120593 [Access: December 28, 2022]. doi:10.5455/PBS.20221012042348


AMA (American Medical Association) Style

Sarioglu S, Tufan AE, Ozturk Y, Ozdemir D. Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder. PBS. 2022; 12(4): 210-211. doi:10.5455/PBS.20221012042348



Vancouver/ICMJE Style

Sarioglu S, Tufan AE, Ozturk Y, Ozdemir D. Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder. PBS. (2022), [cited December 28, 2022]; 12(4): 210-211. doi:10.5455/PBS.20221012042348



Harvard Style

Sarioglu, S., Tufan, . A. E., Ozturk, . Y. & Ozdemir, . D. (2022) Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder. PBS, 12 (4), 210-211. doi:10.5455/PBS.20221012042348



Turabian Style

Sarioglu, Setenay, Ali Evren Tufan, Yusuf Ozturk, and Dilara Ozdemir. 2022. Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder. Psychiatry and Behavioral Sciences, 12 (4), 210-211. doi:10.5455/PBS.20221012042348



Chicago Style

Sarioglu, Setenay, Ali Evren Tufan, Yusuf Ozturk, and Dilara Ozdemir. "Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder." Psychiatry and Behavioral Sciences 12 (2022), 210-211. doi:10.5455/PBS.20221012042348



MLA (The Modern Language Association) Style

Sarioglu, Setenay, Ali Evren Tufan, Yusuf Ozturk, and Dilara Ozdemir. "Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder." Psychiatry and Behavioral Sciences 12.4 (2022), 210-211. Print. doi:10.5455/PBS.20221012042348



APA (American Psychological Association) Style

Sarioglu, S., Tufan, . A. E., Ozturk, . Y. & Ozdemir, . D. (2022) Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder. Psychiatry and Behavioral Sciences, 12 (4), 210-211. doi:10.5455/PBS.20221012042348